A phase I-II Trial of Gleevec (imatinib mesylate) [imatinib] in combination with chlorambucil in previously treated chronic lymphocytic leukemia (CLL) patients.

Trial Profile

A phase I-II Trial of Gleevec (imatinib mesylate) [imatinib] in combination with chlorambucil in previously treated chronic lymphocytic leukemia (CLL) patients.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 16 Apr 2010

At a glance

  • Drugs Chlorambucil; Imatinib
  • Indications Chronic lymphocytic leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Apr 2010 Actual patient number (13) added as reported by ClinicalTrials.gov.
    • 17 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 27 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top